山东中农联合生物科技股份有限公司2025年度业绩预告

Group 1 - The company expects a net profit to be negative for the fiscal year 2025, covering the period from January 1, 2025, to December 31, 2025 [2] - The preliminary estimate of the performance forecast has not been audited by the accounting firm, but there are no significant disagreements between the company and the accounting firm regarding the forecast [2][3] - The decline in the company's main product market prices has led to a low gross profit margin, and the high costs during the trial operation of newly established projects have contributed to an increase in the reported losses [3] Group 2 - The company's stock experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over two consecutive trading days [7] - The company has verified that there are no undisclosed significant matters that could impact the stock price, and the production and operational conditions remain normal [8] - The company confirms that there are no significant undisclosed matters or changes in the external operating environment that could affect the stock trading [8]